The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. MAPS PBC strives to establish a supportive, equitable and accessible work environment.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 350, to expand medical cannabis access. Legislation is pending, House Bill 335, to expand access to medical cannabis in New Hampshire. Click here to email your lawmakers in support of medical access.

Legislation 195

Legislation Decriminalization Hemp Patients 195

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Click here to email your lawmakers in support of banking access. John Fetterman, Lt. CA resident? CA resident? CO resident? Connecticut.

Legislation 163

Legislation Decriminalization Access Patients 163

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some 170 hospitals will participate in the two-year experiment.

Law 113

Law Epilepsy Programs Patients 113

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Send a message to your lawmakers in support of access to edibles. Send a message to your lawmakers in opposition to arbitrary THC limits.

Legislation 146

Legislation Decriminalization Patients Edibles 146

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. Even though the use of CBD for medicine has the support of the FDA, the methods of extracting CBD and the marketing of CBD products will likely become the subjects of high scrutiny.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

The Cannigma

JANUARY 21, 2021

It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. For some conditions, like hypertension, CBG shows potential benefits that CBD doesn’t. CBG vs CBD.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Several veteran’s groups advocate for greater access to medical marijuana. Current Issues in Marijuana Regulation. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. Norway has an official medical cannabis system, but its access is extremely limited and prescriptions are difficult to obtain (Wikimedia). In addition, 29.2%

Legalization 59

Legalization Decriminalization Patients Medicine 59

Cannabis Law Report

JUNE 16, 2021

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory. Corey Herscu for TruTrace Technologies.

Events 74

Events Access Legislation Conditions 74

Cannabis Law Report

JUNE 7, 2019

The farm is run by GW Pharmaceuticals, where around two million cannabis plants have been produced since its opening in 1998. But not everyone suffering from these conditions will be able to access it. Something has finally happened in Sittingbourne. Kent Live Report. It’s location was previously regarded as a secret.

Chronic Pain 40

Chronic Pain Epilepsy Legalization Pharmaceutical 40

Cannabis Law Report

JUNE 9, 2021

Research indicates that psychedelics have the potential to be a breakthrough in treating PTSD, depression, addiction, and other conditions. MAPS is committed to bringing these healing modalities to the world and providing them in such a way that communities that most need mental health resources have access to them. outside counsel).

Research and Development 76

Research and Development Compliance Compliance Education 76

The Cannigma

AUGUST 29, 2021

The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. Access to healthcare professionals. Which conditions medical marijuana may help.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. The authors note that marijuana policy reform has made cannabis widely available for both medical and recreational.

Patients 52

Patients Treatment Therapy Sleep 52

CannaTech

AUGUST 9, 2018

It wasn’t until the second time that I tried CBD, that I forgot to take my usual pharmaceutical anti-epileptic medication. Unlike me, she is based in the UK, and therefore we still don’t have access to medical cannabis for her. But the main push stems from our fight to gain access to this medicine for my sister Tamsin.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

FEBRUARY 3, 2022

Nimbus Health is a privately owned, licensed pharmaceutical wholesaler from Germany focusing on medical cannabis in Germany. The closing of the transaction is subject to customary closing conditions. As more European countries adopt the usage of medical cannabis, the ability to leverage and access newer geographies will be key.

Pharmaceutical 52

Pharmaceutical Events Patients Medicine 52

Weedistry

DECEMBER 29, 2018

Two years ago, the people of Florida overwhelmingly voted to approve Amendment 2, creating a constitutional right for those with medical conditions to seek treatment through medical marijuana. Before the amendment was passed, opponents said that approving access to medical marijuana would result in a veritable plague of social ills.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

JUNE 26, 2019

I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. I used to be a pharmaceutical statistic of opiate and controlled substance pain medications, alongside 25 other Multiple Sclerosis symptom-fighting medications for seven long years.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

SMPL

MAY 28, 2020

The Louisiana Senate approved a bill to significantly expand the state’s medical marijuana program on Wednesday, and a committee advanced separate legislation on banking access for cannabis businesses. Under current law there are only 14 conditions that qualify patients for marijuana. A bill introduced by Rep.

Marijuana 40

Marijuana Legislation Conditions Banking 40

The Cannigma

OCTOBER 20, 2021

In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. Is CBD legal in Switzerland?

Legalization 52

Legalization Decriminalization Patients Medicine 52

Cannabis Law Report

FEBRUARY 27, 2020

Subject to the conditions precedent and material terms of the Agreement, as set out below, LGP will sell and export to DEMECAN up to 1,000kg of LGP-cultivated dried cannabis flower or 48,000 units of LGP Classic medicinal cannabis oil product, or any combination thereof, per annum (the “ Annual Quota ”). Material terms of the Agreement.

Medicine 59

Medicine Oil Cultivation Pharmaceutical 59

Cannabis Law Report

JUNE 10, 2021

Willow is a Canadian biotechnology company that develops and produces high-purity, plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. Willow’s manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers. Forward-Looking Statements.

Research and Development 66

Research and Development Cannabinoids Pharmaceutical Policy 66

Cannabis Law Report

NOVEMBER 22, 2019

According to the proposed text, the commercialization is conditioned to the proof of therapeutic efficacy of the medication, duly attested by medical report for all cases of indication of use. Brazilian public policy on the use of cannabis sativa for medicinal purposes is moving slowly. 399/15 intends to amend article 2 of Law No.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

Cannabis Law Report

MAY 18, 2022

He pinpoints why Australia is one of the best international markets outside of North America for Compass’s expansion: Positive regulatory environment, including eased conditions for over-the counter sales of medicinal cannabis products. Medicinal cannabis is used to treat a range of conditions, including: cancer. chronic pain.

Medicine 52

Medicine Patients Chronic Pain Research and Development 52

Medicinal Genomics

SEPTEMBER 4, 2020

Did a stint in the pharmaceutical business. Later, a very productive stint in the pharmaceutical business working on some of the very largest drug franchises rounded out his education and created the impetus to start his own testing lab business in 2011. We have access to so much data and sharing it is powerful. Claim to Fame.

Hemp 52

Hemp Pharmaceutical Agriculture History 52

Weedistry

JANUARY 30, 2019

These products are also formulated correctly and to what I would call pharmaceutical standards, which is what you want people with compromised immune systems taking into their bodies,” he said. Thousands of new patients are expected to be added if the cannabis law ends qualifying conditions. Lobbying and marijuana policy.

Recreational 40

Recreational Marijuana Legislation Patients 40

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Veterans groups advocating for more access to cannabis, meanwhile, are applauding the newly-published study. Establishing cannabis as safe.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

The Cannigma

JUNE 15, 2021

For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. More and more CBD products on the market promise relief from pain, depression, anxiety, neurodegenerative conditions, and a plethora of other symptoms and conditions. Easy access. Sonya Yruel/Drug Policy Alliance).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2. Criterion 3.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JUNE 15, 2021

Charleen’s edible line serviced a variety of clientele with chronic medical conditions, and those who lack access to cannabis. Bringing over 10 years of pharmaceutical experience to the cannabis industry, Lanett Austin is the Director of Talent Management and Diversity at Curaleaf. exchange (NASDAQ: KERN).

Events 71

Events Dispensary Food Edibles 71

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2. Criterion 3.

Law 40

Law Marijuana Education Cultivation 40